Investigation of Single Rising Doses of BI 685509

NCT02694354 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

16

Enrollment

INDUSTRY

Sponsor class

Conditions

Healthy

Interventions

DRUG: BI 685509
DRUG: Placebo

Sponsor

Boehringer Ingelheim